These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 26364618)

  • 1. Second trimester amniotic fluid myo-inositol concentrations in women later developing gestational diabetes mellitus or pregnancy-induced hypertension.
    Santamaria A; Corrado F; Baviera G; Carlomagno G; Unfer V; D'anna R
    J Matern Fetal Neonatal Med; 2016; 29(14):2245-7. PubMed ID: 26364618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Association between amniotic fluid insulin in the second trimester, maternal glucose tolerance and fetal malformations].
    Bühling KJ; Mönnich J; Henrich W; Brauer M; Heinze T; Siebert G; Dudenhausen JW
    Z Geburtshilfe Neonatol; 2004 Dec; 208(6):226-31. PubMed ID: 15647986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Are myo-inositol, glucose and zinc concentrations in amniotic fluid of fetuses with spina bifida different from controls?
    Groenen PM; Wevers RA; Janssen FS; Tuerlings JH; Merkus JM; Steegers-Theunissen RP
    Early Hum Dev; 2003 Feb; 71(1):1-8. PubMed ID: 12614945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and metabolic outcomes in pregnant women at risk for gestational diabetes mellitus supplemented with myo-inositol: a secondary analysis from 3 RCTs.
    Santamaria A; Alibrandi A; Di Benedetto A; Pintaudi B; Corrado F; Facchinetti F; D'Anna R
    Am J Obstet Gynecol; 2018 Sep; 219(3):300.e1-300.e6. PubMed ID: 29859136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Second trimester maternal plasma and amniotic fluid adipokines in women who will develop gestational diabetes mellitus.
    Fruscalzo A; Londero AP; Biasizzo J; Curcio F; Bertozzi S; Marchesoni D; Driul L
    Gynecol Endocrinol; 2015; 31(12):934-8. PubMed ID: 26369835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Midtrimester amniotic fluid leptin and insulin levels and subsequent gestational diabetes.
    D'Anna R; Baviera G; Cannata ML; De Vivo A; Di Benedetto A; Corrado F
    Gynecol Obstet Invest; 2007; 64(2):65-8. PubMed ID: 17264515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myo-inositol in Down syndrome amniotic fluid. A case-control study.
    Santamaria A; Corrado F; Interdonato ML; Baviera G; Carlomagno G; Cavalli P; Unfer V; D'Anna R
    Prenat Diagn; 2014 Sep; 34(9):917-8. PubMed ID: 24933110
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of fetal hyperinsulinism on oral glucose tolerance test results in patients with gestational diabetes mellitus.
    Weiss PA; Scholz HS; Haas J; Tamussino KF
    Am J Obstet Gynecol; 2001 Feb; 184(3):470-5. PubMed ID: 11228505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibroblast growth factor 2 is elevated in term maternal and cord serum and amniotic fluid in pregnancies complicated by diabetes: relationship to fetal and placental size.
    Hill DJ; Tevaarwerk GJ; Caddell C; Arany E; Kilkenny D; Gregory M
    J Clin Endocrinol Metab; 1995 Sep; 80(9):2626-32. PubMed ID: 7673405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Correlation between amniotic fluid glucose concentration and amniotic fluid volume and neonatal birth weight in pregnancy complicated by gestational diabetes mellitus].
    Xu ZM; Wu LF
    Zhonghua Fu Chan Ke Za Zhi; 2006 Nov; 41(11):724-8. PubMed ID: 17327026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relationship between second-trimester amniotic fluid insulin and glucose levels and subsequent gestational diabetes.
    Star J; Canick JA; Palomaki GE; Carpenter MW; Saller DN; Sung CJ; Tumber MB; Coustan DR
    Prenat Diagn; 1997 Feb; 17(2):149-54. PubMed ID: 9061763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of dietary myo-inositol supplementation in pregnancy on the incidence of maternal gestational diabetes mellitus and fetal outcomes: a randomized controlled trial.
    Matarrelli B; Vitacolonna E; D'Angelo M; Pavone G; Mattei PA; Liberati M; Celentano C
    J Matern Fetal Neonatal Med; 2013 Jul; 26(10):967-72. PubMed ID: 23327487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated amniotic fluid leptin levels in early second trimester are associated with earlier delivery and lower birthweight in twin pregnancy.
    Chan TF; Chung YF; Chen HS; Su JH; Yuan SS
    Acta Obstet Gynecol Scand; 2004 Aug; 83(8):707-10. PubMed ID: 15255841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences in amniotic fluid patterns and fetal biometric parameters in third trimester pregnancies with and without diabetes.
    Kofinas A; Kofinas G
    J Matern Fetal Neonatal Med; 2006 Oct; 19(10):633-8. PubMed ID: 17118737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resistin in mid-trimester amniotic fluid in trisomy 21.
    Vrachnis N; Gkogkas L; Iliodromiti S; Grigoriadis C; Samoli E; Iliodromiti Z; Pangalos C; Pappa KI; Drakoulis N; Creatsas G; Botsis D
    J Matern Fetal Neonatal Med; 2013 Nov; 26(16):1576-80. PubMed ID: 23544842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary Excretion of Myo-Inositol and D-Chiro-Inositol in Early Pregnancy Is Enhanced in Gravidas With Gestational Diabetes Mellitus.
    Murphy A; Shamshirsaz A; Markovic D; Ostlund R; Koos B
    Reprod Sci; 2016 Mar; 23(3):365-71. PubMed ID: 26355118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amniotic fluid insulin testing in gestational diabetes: safety and acceptance of amniocentesis.
    Haeusler MC; Konstantiniuk P; Dorfer M; Weiss PA
    Am J Obstet Gynecol; 1998 Oct; 179(4):917-20. PubMed ID: 9790370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myo-inositol may prevent gestational diabetes in PCOS women.
    D'Anna R; Di Benedetto V; Rizzo P; Raffone E; Interdonato ML; Corrado F; Di Benedetto A
    Gynecol Endocrinol; 2012 Jun; 28(6):440-2. PubMed ID: 22122627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myo-inositol may prevent gestational diabetes onset in overweight women: a randomized, controlled trial.
    Santamaria A; Di Benedetto A; Petrella E; Pintaudi B; Corrado F; D'Anna R; Neri I; Facchinetti F
    J Matern Fetal Neonatal Med; 2016 Oct; 29(19):3234-7. PubMed ID: 26698911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential role and therapeutic interests of myo-inositol in metabolic diseases.
    Croze ML; Soulage CO
    Biochimie; 2013 Oct; 95(10):1811-27. PubMed ID: 23764390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.